Skip to main content
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
13.03
-1.92 (-12.84%)
At close: Apr 28, 2026, 4:00 PM EDT
13.27
+0.24 (1.84%)
After-hours: Apr 28, 2026, 7:54 PM EDT

Relay Therapeutics Revenue

In the year 2025, Relay Therapeutics had annual revenue of $15.36M with 53.44% growth. Relay Therapeutics had revenue of $7.00M in the quarter ending December 31, 2025.

Revenue (ttm)
$15.36M
Revenue Growth
+53.44%
P/S Ratio
160.56
Revenue / Employee
$79,974
Employees
192
Market Cap
2.47B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202515.36M5.35M53.44%
Dec 31, 202410.01M-15.54M-60.83%
Dec 31, 202325.55M24.17M1,749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ultragenyx Pharmaceutical 673.00M
ADMA Biologics 510.17M
Zai Lab 460.16M
Tarsus Pharmaceuticals 451.36M
IDEAYA Biosciences 218.71M
Soleno Therapeutics 190.41M
Immunome 6.94M
Celldex Therapeutics 1.55M
Revenue Rankings

RLAY News

More News